Published online Nov 27, 2021. doi: 10.4240/wjgs.v13.i11.1372
Peer-review started: July 29, 2021
First decision: October 3, 2021
Revised: October 6, 2021
Accepted: October 27, 2021
Article in press: October 27, 2021
Published online: November 27, 2021
Processing time: 120 Days and 11 Hours
Although the “Step-up” strategy is the primary surgical treatment for infected pancreatic necrosis, it is not suitable for all infected pancreatic necrosis patients.
The “One-step” strategy represents a novel treatment; however, there is a lack of safety, efficacy, and long-term follow-up clinical data compared with the “Step-up” approach.
This study aimed to compare the safety, efficacy, and long-term follow-up of two surgical approaches.
Patients were retrospectively assessed, with a composite endpoint of severe complications or death as the primary outcome. t-test, chi-square test or Fisher’s exact test, and Kaplan-Meier curves were used for further analysis.
The time from disease onset to hospital admission (53.69 ± 38.14 vs 32.20 ± 20.75, P < 0.001) and to initial surgical treatment was longer in the “Step-up” than in the “One-step” group (54.38 ± 10.46 vs 76.58 ± 17.03, P < 0.001). Patients who underwent “Step-up” necrosectomy had a longer hospitalization duration (65.41 ± 28.14 vs 52.76 ± 24.71, P = 0.02), and more interventions (4.26 ± 1.71 vs 3.18 ± 1.39, P < 0.001). Postoperative inflammatory indicator levels were significantly lower than preoperative levels in each group. Although the incisional hernia incidence was higher in the “One-step” group, there were no significant differences in other observation indicators.
The “One-step” approach is a safe and effective treatment method with better long-term quality of life and prognosis.
The “One-step” approach provides an alternative surgical treatment strategy for patients with infected pancreatic necrosis.